IPO Price History
Closed
Akums Drugs and Pharmaceuticals Limited logo

Akums Drugs and Pharmaceuticals Limited IPO

Mainboard IPOListedAKUMSNSE
Current Market Price (CMP)
₹669(-1.47%)
Current Price (CMP)
₹669(-1.47%)

Live Market Quote

Listing Price & Gain
₹725(+6.77%)

Day 1 Exchange Open

IPO Issue Price
₹679

Band: ₹646 - ₹679

Total Subscription
63.56x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
30 Jul 2024
IPO Bidding Closes
01 Aug 2024
Allotment & Refunds
Completed
Exchange Listing Day
06 Aug 2024

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 63.56x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)90.09x
Non-Institutional Investors (NII / HNI)42.21x
Retail Individual Investors (RII)21.3x
Employees Reservation4.27x
Total Subscription63.56x
Updated as on 01-Aug-2024 19:00:00

Listing Day & Return Performance

Listing Day Gain+6.77%
₹679 (Issue) → ₹725 (List)
Per share profit: +₹46.00
Holding Return (Till Date)-1.47%
₹679 (Issue) → ₹669 (CMP)
Net gain per share: ₹-10.00
Post-Listing Performance (Listing Day → Today):-7.72%

About Akums Drugs and Pharmaceuticals Limited IPO

Akums Drugs and Pharmaceuticals Limited is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 30 Jul 2024 and concluded on 01 Aug 2024, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹646 - ₹679.

During the bidding window, Akums Drugs and Pharmaceuticals Limited witnessed heavy demand with an overall subscription of 63.56 times. Institutional investors (QIB) subscribed 90.09x, non-institutional high-net-worth investors (NII) subscribed 42.21x, and retail individual investors (RII) bid 21.3x their reserved quota, alongside employee participation of 4.27x.

The equity shares of Akums Drugs and Pharmaceuticals Limited officially debuted on the stock exchanges on 06 Aug 2024 at an opening listing price of ₹725, delivering a listing day return of +6.77% (premium) over the final issue price. As per the latest market data, the stock trades at ₹669, representing an overall decline of -1.47% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Akums Drugs and Pharmaceuticals Limited IPO?
The issue price of Akums Drugs and Pharmaceuticals Limited IPO was fixed at ₹679 per equity share. The indicative bidding price band was ₹646 - ₹679.
What were the open, close, and listing dates for Akums Drugs and Pharmaceuticals Limited IPO?
Akums Drugs and Pharmaceuticals Limited IPO opened on 30 Jul 2024, closed on 01 Aug 2024, listed on 06 Aug 2024.
How much was Akums Drugs and Pharmaceuticals Limited IPO subscribed?
The IPO received an overall subscription of 63.56 times. Category-wise, QIBs subscribed 90.09x, NIIs subscribed 42.21x, and Retail investors subscribed 21.3x.
What was the listing price and listing gain of Akums Drugs and Pharmaceuticals Limited IPO?
Akums Drugs and Pharmaceuticals Limited IPO listed on the stock exchange at ₹725, delivering a listing gain of 6.77% compared to the IPO issue price of ₹679.
Is Akums Drugs and Pharmaceuticals Limited IPO a Mainboard or SME IPO?
Akums Drugs and Pharmaceuticals Limited IPO is a Mainboard IPO listed on the main exchange of NSE.
What is the current return of Akums Drugs and Pharmaceuticals Limited IPO since its IPO?
At the latest market quote of ₹669, Akums Drugs and Pharmaceuticals Limited IPO has generated an all-time return of -1.47% since its initial public offering.

Related Mainboard IPOs (2024)

UNIMECH
Unimech Aerospace and Manufacturing Limited
₹785+85.99%
VENTIVE
Ventive Hospitality Limited
₹643+11.35%
CARRARO
Carraro India Limited
₹704-7.53%
SENORES
Senores Pharmaceuticals Limited
₹391+53.45%